Ashish Muglikar is a
nanomedicine researcher with expertise in lipid nanoparticles (LNPs),
parenteral drug delivery, and sterile injectable formulations. He holds an
M.Pharm in Pharmaceutics and an MSc in Advanced Drug Delivery from the
University of Strathclyde, UK. His previous research at CMAC/Strathclyde
focused on nanomedicine and nucleic-acid delivery. He currently works in
industry as a Research Associate in Early-Stage Formulation Process Development
at BioNTech SE. His skills include LNP development, nucleic-acid delivery
systems, and formulation work for injectable products.
Ashish Muglikar is a
nanomedicine researcher with expertise in lipid nanoparticles (LNPs),
parenteral drug delivery, and sterile injectable formulations. He holds an
M.Pharm in Pharmaceutics and an MSc in Advanced Drug Delivery from the
University of Strathclyde, UK. His previous research at CMAC/Strathclyde
focused on nanomedicine and nucleic-acid delivery. He currently works in
industry as a Research Associate in Early-Stage Formulation Process Development
at BioNTech SE. His skills include LNP development, nucleic-acid delivery
systems, and formulation work for injectable products.